Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

5-HT3 receptor antagonists

M B Tyers1

  • 1Department of Neuropharmacology, Glaxo Group Research Ltd, Hertfordshire, UK.

Drug Design and Delivery
|January 1, 1991
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GR127935: a potent and selective 5-HT1D receptor antagonist.

Behavioural brain research·1996
Same author

GR159897, a potent non-peptide antagonist at tachykinin NK2 receptors.

European journal of pharmacology·1995
Same author

Anxiolytic activity of tachykinin NK2 receptor antagonists in the mouse light-dark box.

European journal of pharmacology·1993
Same author

Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse.

Psychopharmacology·1993
Same author

Site(s) and mechanisms of the anti-emetic action of 5-HT3 receptor antagonists: a discussion of Professor Naylor's paper.

The British journal of cancer. Supplement·1992
Same author

Pharmacology and preclinical antiemetic properties of ondansetron.

Seminars in oncology·1992
Same journal

The use of micronized cellulose disintegrants as insoluble swellable matrices for sustained-release tablets.

Drug design and delivery·1991
Same journal

Controlled release microspheres based on Eudragit L100 for the oral administration of erythromycin.

Drug design and delivery·1991
Same journal

Synthesis and anti-inflammatory activity of 5-(1,4-dihydropyridyl)-tetrazol-2-acetic acids, esters and amides.

Drug design and delivery·1991
Same journal

Molecular modification of anticholinergics as probes for muscarinic receptors. Part 4. Ileal selective muscarinic antagonists.

Drug design and delivery·1991
Same journal

Inhibition of cholesterol side-chain cleavage. Part 5. Synthesis of 22-(p-chlorophenyl) cholesterol analogues.

Drug design and delivery·1991
Same journal

Prolongation of drug release by covalent bonding of drugs to serum albumin microbeads.

Drug design and delivery·1991
See all related articles